Serial 86836956

Live / Registered — Registered — partial Section 8 accepted (as of 04 Apr 2025)

What this means for you

Registered since 13 Mar 2018. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
86836956
Registration number
5420871
Mark type
Design / logo
Filed
02 Dec 2015
Published for opposition
06 Jun 2017
Registered
13 Mar 2018
Attorney of record
Nancy Sabarra

Goods and services

  • Class 001 — Chemicals: [ Chemical and biological reagents for scientific use and/or for non-medical purposes; cell cultures and media for scientific use and/or for non-medical purposes; chemical test kits for scientific and laboratory use for anti-body screening, blood grouping or for detection of specific blood cells, antigens or immunoglobulin subtypes; chemical preparations for scientific and/or industrial purposes; diagnostic reagents for scientific use; chemical and biological reagents for non-medical purposes; chemical and biological reagents for industrial use for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for industrial use for anti-body screening, blood grouping, and the typing and detection of specific blood cells ]
  • Class 005 — Pharmaceuticals: Vaccines; [ medicated serums for the treatment of influenza; antibodies for medical use, namely, immunoglobulins; ] influenza vaccines; [ adjuvants for medical purposes for use with vaccines and for immunological purposes; pharmaceutical substances in the nature of antigens, namely, antigen vaccines, antigens for the treatment of influenza, and antigens for development of third party pharmaceutical and immunological products; ] pharmaceutical preparations and substances for the [ treatment and/or ] prevention of [ blood or bleeding disorders, or ] diseases caused [ by bacteria and ] viruses [ ; blood products for medical use, namely, blood plasma, reagent blood cells; products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for medical therapeutic use; medicated serums, namely, anti-venoms for treatment of bites and stings; medicated serums for the treatment of blood or bleeding disorders; test kits, namely, invitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substances, namely, Rheysys Factor D Antigen reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies or immunoglobulin subtypes; pharmaceutical preparations, namely, monoclonal and polyclonal antibodies; pharmaceutical preparations, namely, reagents for medical/clinical use for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes ]
  • Class 044 — Medical, beauty and agricultural services: [ Medical services; medical information services; health care services, namely, nursing services; health care information services; health care services, namely, medical services in the nature of patient support services and programs; health care services, namely, medical services in the nature of providing medical information concerning blood products, and providing medical information concerning vaccines, anti-venoms and immunohematology products in the nature of diagnostic reagents; medical services, namely, patient support services in the nature of providing medical information, including patient medical information, via an internet database, where patients can enquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community ]

Owner

Prosecution history

  • 04 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
  • 04 Apr 2025 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
  • 04 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 09 Sept 2024 — TEAS SECTION 8 RECEIVED
  • 13 Mar 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 25 Nov 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 25 Nov 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 18 Dec 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 18 Dec 2018 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 13 Mar 2018 — REGISTERED-PRINCIPAL REGISTER
  • 05 Feb 2018 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
  • 25 Jan 2018 — NOTICE OF ALLOWANCE CANCELLED
  • 05 Feb 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 25 Jan 2018 — TEAS DELETE 1(B) BASIS RECEIVED
  • 01 Aug 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT

View this trademark record on Marksy